We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring

By LabMedica International staff writers
Posted on 17 Mar 2025

Current sensors can measure various health indicators, such as blood glucose levels, in the body. More...

However, there is a need to develop more accurate and sensitive sensor materials that can detect lower concentrations of certain substances. For instance, female hormones are present in the body at concentrations millions of times lower than glucose. To effectively study hormone fluctuations, highly sensitive sensors are required, and this necessitates a significant improvement in the accuracy of biosensors. In a new study, researchers have developed nanomaterials that could contribute to more accurate sensors for future healthcare applications. These advancements could lead to continuous health monitoring, enabled by carbon nanotubes.

Researchers at the University of Turku (Turku, Finland) have successfully created sensors using single-wall carbon nanotubes, which are well-suited for such applications. Single-wall carbon nanotubes are made from a single atomic layer of graphene. Until now, a major challenge in developing these materials has been that the nanotube manufacturing process yields a mix of conductive and semi-conductive nanotubes, which vary in chirality—the way the graphene sheet is rolled into the cylindrical shape of the nanotube. The electrical and chemical properties of nanotubes are highly dependent on their chirality. The research team developed methods to separate nanotubes with different chiralities, and in this study, they successfully distinguished between two nanotubes with similar chiralities while identifying their typical electrochemical properties.

By purifying and separating the carbon nanotubes, the researchers were able to test their differences as sensor materials. Although nanotubes are typically used in hybrid sensors when combined with other surfactants, the current study focused on sensors made entirely from nanotubes. Furthermore, the researchers gained precise control over the concentration of nanotubes, allowing them to compare the properties of different chiralities. One key finding was that one type of nanotube (6.5) was more efficient than the other (6.6) in adsorbing dopamine. Adsorption, which refers to the ability of a material to bind atoms or molecules to its surface, is especially crucial when the concentrations of the substances being measured are very low. The study's results are the first to demonstrate that the electrochemical response of the sensor is influenced by chirality. In future research, computational models could be employed to determine the optimal chirality for measuring each molecule.

“The result is significant because by being able to precisely control the properties of carbon nanotubes we can fine-tune the ability of the sensor material to detect changes in specific substances," said Doctoral Researcher Ju-Yeon Seo.

Related Links:
University of Turku


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.